Risk of venous thromboembolism and oral contraceptives [5] (multiple letters)

Lancet

Volumn 359, Issue 9314, 2002, Pages 1348-1349

  Campodonico, Fabio ^a   Carmignani, Giorgio ^a   Gompel, A ^b   Carpentier, S ^c   Frances C ^c   Piette, J C ^c  

^a UNIVERSITY OF GENOA   (Italy)

^b HÔTEL DIEU   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYPROTERONE; HEPARIN; LEVONORGESTREL; ORAL CONTRACEPTIVE AGENT; POTASSIUM ION; SODIUM CHLORIDE; ANTIANDROGEN; CYPROTERONE ACETATE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ANOREXIA; CASE REPORT; CLINICAL FEATURE; DEEP VEIN THROMBOSIS; DEHYDRATION; DISEASE ASSOCIATION; ELECTROCARDIOGRAM; FEMALE; HUMAN; KIDNEY VEIN THROMBOSIS; LABORATORY TEST; LETTER; PRIORITY JOURNAL; QT INTERVAL; RISK FACTOR; THROMBOEMBOLISM; URINALYSIS; CHEMICALLY INDUCED DISORDER; NOTE; SYSTEMIC LUPUS ERYTHEMATOSUS; VEIN THROMBOSIS; ANOREXIA NERVOSA;

ANDROGEN ANTAGONISTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CONTRACEPTIVES, ORAL; CYPROTERONE ACETATE; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; RISK FACTORS; VENOUS THROMBOSIS; ADULT; ANOREXIA NERVOSA; DEHYDRATION;

EID: 0037070919     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0140-6736(02)08297-1     Document Type: Letter

References (4)

1. C Vasilakis-Scaramozza H Jick Risk of venous thromboembolism with cyproterone or levonorgestrel contraceptives Lancet 358 2001 1427 1429
2. JM Kemmeren A Algra DE Grobbee Third generation oral contraceptives and risk of venous thrombosis: meta-analysis BMJ 323 2001 131 134
3. N van der Vange HJ Kloosterboer AA Haspels Effects of seven low dose combined oral contraceptives on high density lipoprotein subfractions Br J Obstet Gynaecol 1987 559 567
4. DG Wahl F Guillemin E de Maistre C Perret T Lecompte G Thibaut Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus: a meta-analysis Lupus 6 1997 467 473